Polymer Neurovascular Stent Sales

Polymer Neurovascular Stent Sales Market Outlook

The global Polymer Neurovascular Stent Market is projected to reach an impressive valuation of approximately USD 2.5 billion by 2035, registering a compound annual growth rate (CAGR) of around 7.2% during the forecast period from 2025 to 2035. The growing prevalence of neurovascular diseases, such as aneurysms and stenosis, coupled with the increasing demand for minimally invasive procedures, is driving the market's growth. Additionally, advancements in polymer materials that enhance biocompatibility and reduce the risk of thrombosis are significantly contributing to the expansion of this market. As healthcare infrastructure improves and more patients have access to specialized neurovascular treatments, the adoption of polymer stents is expected to increase, thereby fueling market growth. Investment in research and development by companies to innovate and improve stent designs also plays a key role in this market's trajectory.

Growth Factor of the Market

One of the key growth factors driving the Polymer Neurovascular Stent Market is the increasing incidence of neurovascular diseases, which is prompting the need for advanced treatment options. As more patients are diagnosed with conditions such as ischemic stroke and cerebral aneurysms, the demand for effective and reliable vascular intervention tools like polymer stents is surging. Moreover, technological advancements such as the development of drug-eluting stents that release therapeutic agents to prevent restenosis have gained traction, further enhancing treatment outcomes. Additionally, the rising preference for minimally invasive surgical procedures is contributing to the growing adoption of polymer-based stents due to their flexibility and lower rates of complications. Furthermore, healthcare providers are increasingly focusing on improving patient outcomes, which is reflected in the adoption of innovative stent technologies. The proactive initiatives undertaken by governments and healthcare organizations in various regions to enhance awareness and improve healthcare access also play a significant role in supporting market growth.

Key Highlights of the Market

• The Polymer Neurovascular Stent Market is expected to witness significant growth due to the rising prevalence of neurovascular diseases.
• Technological advancements in stent design and materials are driving product innovation and adoption.
• Minimally invasive procedures are gaining popularity, leading to increased demand for polymer neurovascular stents.
• Government initiatives aimed at improving healthcare access and awareness are supporting market expansion.
• The market is characterized by a competitive landscape with numerous players investing in research and development to enhance product offerings.

By Product Type

Self-Expanding Stents:

Self-expanding stents are widely utilized in the Polymer Neurovascular Stent Market due to their ability to adapt to the dimensions of the vessel once deployed. These stents are made of elastic materials that allow them to expand automatically upon release from their delivery system, ensuring optimal contact with the vessel wall and reducing the chances of migration. The growing acceptance of self-expanding stents in the treatment of complex neurovascular conditions, along with their favorable clinical outcomes, is rendering them a preferred choice for healthcare professionals. Moreover, advancements in technology, such as the incorporation of radiopaque markers and improved delivery systems, are enhancing the ease of use and effectiveness of these stents, further driving their market growth.

Balloon-Expandable Stents:

Balloon-expandable stents are another prominent segment within the Polymer Neurovascular Stent Market. These stents are deployed using a balloon catheter that expands the stent to its intended diameter, providing a secure fit against the vessel wall. Their precise placement capabilities and ability to provide immediate support to the vessel make them a preferred choice in certain clinical scenarios. Additionally, the development of advanced balloon technology, such as low-profile balloons and controlled expansion mechanisms, has improved the safety and efficacy of balloon-expandable stents. The increasing number of endovascular procedures for treating neurovascular diseases is significantly contributing to the demand for these stents, leading to their continued growth in the market.

Drug-Eluting Stents:

Drug-eluting stents (DES) represent a transformative innovation in the Polymer Neurovascular Stent Market, designed to release medication that inhibits cell proliferation and minimizes the risk of restenosis. These stents have garnered attention for their efficacy in promoting sustained vessel patency and improving long-term patient outcomes. The continuous advancements in drug formulation and biocompatible coatings are enhancing the performance of drug-eluting stents, making them a vital option for treating complex neurovascular conditions. The increasing clinical evidence supporting the benefits of drug-eluting stents in preventing restenosis is further driving their adoption among healthcare providers, thereby bolstering market growth.

Bare-Metal Stents:

Bare-metal stents have been a foundational element in the Polymer Neurovascular Stent Market, known for their simplicity and effectiveness in providing scaffolding within the vessel. Although they lack the drug-eluting capabilities of their counterparts, bare-metal stents are preferred in specific patient populations where the risk of thrombosis is lower or where immediate vessel support is critical. Their ease of manufacturing and lower cost compared to drug-eluting stents contribute to their continued relevance in certain clinical applications. As healthcare providers assess the risks and benefits of various stent types, bare-metal stents maintain a loyal following in the therapeutic arsenal for neurovascular diseases.

Bioresorbable Stents:

Bioresorbable stents represent a novel approach in the Polymer Neurovascular Stent Market, designed to provide temporary support to the vessel while gradually being absorbed by the body. This innovative technology seeks to address concerns associated with permanent implants, such as long-term foreign body reactions. Bioresorbable stents are particularly beneficial in treating conditions where long-term vessel support is not necessary, allowing for natural vessel healing post-implantation. The growing body of research supporting the safety and efficacy of bioresorbable stents is driving interest from both healthcare professionals and patients, thereby contributing to their anticipated growth in the market as a viable alternative.

By Application

Hospitals:

Hospitals are the primary application segment for polymer neurovascular stents, accounting for a significant share of the market. The increasing number of neurovascular procedures performed in hospital settings, driven by the rising incidence of strokes and aneurysms, underscores the importance of these medical facilities in the overall supply chain. Hospitals typically possess the necessary infrastructure, advanced imaging technologies, and skilled healthcare professionals required for performing complex endovascular procedures. Furthermore, the collaboration between hospitals and specialized neurovascular intervention teams is fostering an environment conducive to the implementation of innovative stenting technologies, further enhancing the demand for polymer neurovascular stents.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are emerging as a significant application area for polymer neurovascular stents, owing to their ability to provide cost-effective, minimally invasive treatment options in a patient-friendly environment. These centers are gaining traction as alternatives to traditional hospital settings, especially for elective and less complex neurovascular procedures. The growing trend of outpatient surgeries and the advancements in surgical techniques are propelling the adoption of polymer stents in ASCs. Moreover, the focus on enhancing patient satisfaction and reducing recovery times is driving healthcare providers to consider ASCs as viable options for delivering neurovascular interventions.

Specialty Clinics:

Specialty clinics are also contributing to the growth of the Polymer Neurovascular Stent Market by providing focused care for patients with specific neurovascular conditions. These clinics often employ specialized teams of vascular surgeons and neurologists with expertise in managing complex neurovascular disorders, enabling personalized treatment plans for patients. The convenience of receiving care in a specialized setting, coupled with advancements in stenting technologies, is increasing patient referrals to these clinics. As awareness regarding the importance of early intervention in neurovascular diseases grows, specialty clinics are expected to play a crucial role in the adoption of polymer stents.

By Distribution Channel

Hospitals Pharmacies:

Hospital pharmacies serve as a key distribution channel for polymer neurovascular stents, ensuring that healthcare professionals have immediate access to the required devices for surgical procedures. These pharmacies are integral to the hospital's supply chain, often working closely with manufacturers to manage inventory levels and procurement processes. The established relationships between hospitals and stent manufacturers facilitate streamlined access to the latest products and technologies. Furthermore, hospital pharmacies typically maintain rigorous quality control standards, ensuring that the stents provided meet regulatory requirements and are suitable for clinical use. This high level of oversight and reliability contributes to the continued demand for polymer stents in hospital settings.

Retail Pharmacies:

Retail pharmacies are witnessing an increasing role in the Polymer Neurovascular Stent Market as they expand their service offerings to cater to outpatient needs. While traditional retail pharmacies primarily focused on medication dispensing, many are now incorporating diagnostic and therapeutic services. This shift allows them to stock certain neurovascular devices, including polymer stents, to meet the needs of patients who may require follow-up care post-discharge from hospitals. As patients seek more accessibility to medical products and services, the presence of polymer stents in retail pharmacies could enhance convenience and improve overall patient outcomes.

Online Pharmacies:

Online pharmacies have gained significant traction in the Polymer Neurovascular Stent Market, particularly in light of the growing trend towards digital healthcare solutions. With the increased adoption of e-commerce and telemedicine, patients and healthcare providers can access stenting products more conveniently through online channels. Online pharmacies often provide a wider selection of products and competitive pricing, making them an attractive option for medical professionals seeking to purchase polymer neurovascular stents. Additionally, the ease of ordering and delivery, coupled with the ability to access detailed product information, supports the growing preference for online procurement of medical devices.

By Material Type

Polyethylene:

Polyethylene is a commonly used material in the production of polymer neurovascular stents due to its excellent mechanical properties and biocompatibility. This thermoplastic material is highly flexible, allowing stents to conform to the vessel's contours upon deployment. Polyethylene stents offer a favorable balance of strength and elasticity, reducing the risk of fractures during insertion and providing reliable vessel support. Moreover, the ease of processing and molding polyethylene contributes to the efficient manufacturing of stents, which is crucial for meeting the growing demand in the market. As the understanding of polyethylene's interactions within the biological environment continues to evolve, its utilization in neurovascular stents is expected to remain significant.

Polypropylene:

Polypropylene is another prominent material used in polymer neurovascular stents, favored for its lightweight nature and high tensile strength. These characteristics make it an ideal choice for creating stents that can maintain structural integrity while navigating complex vascular pathways. Polypropylene's resistance to degradation in physiological environments further enhances its applicability in neurovascular treatments. Additionally, the ability to modify polypropylene's properties through chemical treatments allows for the development of stents that can meet specific clinical requirements. As clinicians increasingly prioritize material properties that promote optimal patient outcomes, polypropylene-based stents are expected to see continued adoption in the market.

Polycarbonate:

Polycarbonate is recognized for its outstanding impact resistance and dimensional stability, making it a viable material for polymer neurovascular stents. Its robust characteristics provide the necessary support during and after deployment, ensuring the stent effectively maintains its shape and functionality. The biocompatibility of polycarbonate promotes favorable interactions with biological tissues, reducing the likelihood of inflammatory responses post-implantation. Furthermore, advancements in the processing techniques for polycarbonate allow for greater precision in stent design, enabling the creation of customized solutions for complex neurovascular conditions. As the demand for high-performance stents grows, polycarbonate is likely to play a pivotal role in the market.

Polyurethane:

Polyurethane is increasingly being utilized in the Polymer Neurovascular Stent Market, known for its exceptional flexibility and biocompatibility. This material can be engineered to exhibit varying degrees of hardness and elasticity, which is beneficial in designing stents that can adapt to the dynamic environments of blood vessels. Polyurethane stents are less prone to fracture compared to other materials, contributing to their reliability in long-term applications. The material's ability to be modified with bioactive agents further enhances its functionality, allowing for the development of drug-eluting stents that can prevent restenosis. As healthcare providers continue to seek innovative solutions, polyurethane-based stents are expected to gain traction in the market.

Others:

In addition to the primary materials mentioned, there are several other materials being explored for use in polymer neurovascular stents. These may include biodegradable polymers and composite materials that combine the benefits of various substances to enhance performance. The development of alternative materials is driven by the need for stents with improved bioresorption characteristics and reduced complications associated with long-term implants. The exploration of new materials also aligns with ongoing research efforts aimed at developing next-generation stents that promote better healing and minimize adverse reactions. As material science advances, the "others" segment in the polymer neurovascular stent market is likely to expand, offering innovative solutions to meet the evolving needs of healthcare providers and patients alike.

By Region

The North American region holds a significant share of the Polymer Neurovascular Stent Market, driven by the high prevalence of neurological disorders and advanced healthcare infrastructure. The United States, in particular, accounts for a substantial portion of the market due to the presence of leading stent manufacturers and a supportive regulatory environment that fosters innovation. The North American market is projected to grow at a CAGR of approximately 7.5% during the forecast period, fueled by increasing investments in healthcare technology and a growing focus on improving patient outcomes through the use of advanced neurovascular devices.

In Europe, the Polymer Neurovascular Stent Market is experiencing steady growth as healthcare providers increasingly adopt minimally invasive procedures for treating neurovascular diseases. The region benefits from a well-established healthcare system and a growing emphasis on evidence-based medical practices. Countries such as Germany, France, and the UK are at the forefront of this growth, with increasing funding for healthcare initiatives aimed at enhancing the management of neurological disorders. While the European market is expected to maintain a healthy growth rate, it is essential for stakeholders to navigate the varying regulatory frameworks across different countries to capitalize on emerging opportunities.

Opportunities

The Polymer Neurovascular Stent Market presents numerous opportunities for growth driven by the increasing demand for advanced and innovative treatment options for neurovascular diseases. As the aging population grows, the incidence of conditions such as ischemic stroke and aneurysms is expected to rise, creating a greater need for effective stenting solutions. Additionally, the ongoing advancements in materials science and stent design are paving the way for the development of next-generation neurovascular devices that offer improved patient outcomes and reduced complication rates. Companies that invest in research and development to innovate and enhance their product offerings will be well-positioned to capture market share in this expanding landscape. Furthermore, collaborations between medical device manufacturers and healthcare providers can lead to the development of tailored solutions that address specific clinical needs and improve patient care.

Moreover, emerging markets present a significant opportunity for growth in the Polymer Neurovascular Stent Market. As healthcare systems in regions such as Asia Pacific and Latin America continue to evolve and improve, there is an increasing focus on enhancing access to quality healthcare services, including neurovascular interventions. The growing investment in healthcare infrastructure and rising awareness of neurovascular diseases are expected to drive demand for polymer stents in these regions. By establishing strategic partnerships and distribution networks in these emerging markets, companies can capitalize on the expanding patient population and contribute to improving healthcare outcomes for individuals suffering from neurovascular diseases.

Threats

Despite the promising growth prospects of the Polymer Neurovascular Stent Market, there are several threats that could impact its trajectory. One of the primary concerns is the potential for regulatory challenges that may arise in different regions as manufacturers seek to introduce new products to the market. Regulatory bodies often impose stringent guidelines and lengthy approval processes, which can hinder the timely launch of innovative stenting solutions. Furthermore, the increasing scrutiny of medical devices in light of safety and efficacy concerns can also pose significant challenges for companies operating in this space. In this context, manufacturers must ensure compliance with regulatory requirements and invest in robust clinical studies to substantiate the safety and effectiveness of their products.

Another threat to the Polymer Neurovascular Stent Market is the growing competition from alternative treatment options and therapeutic modalities. As medical technology evolves, there is a shift towards non-invasive treatments and alternative therapies that may offer similar or improved patient outcomes. The emergence of new procedures and devices could divert attention from traditional stenting solutions, impacting market demand. Additionally, economic fluctuations and budget constraints within healthcare systems can limit the availability of funds for purchasing advanced medical devices, further challenging manufacturers in maintaining their market positions. As a result, companies must continuously innovate and adapt their strategies to remain competitive in this dynamic market.

Competitor Outlook

• Medtronic
• Boston Scientific Corporation
• Abbott Laboratories
• Cordis Corporation
• MicroVention, Inc.
• Terumo Corporation
• Stryker Corporation
• Johnson & Johnson (Ethicon, Inc.)
• Penumbra, Inc.
• B. Braun Melsungen AG
• Asahi Intecc Co., Ltd.
• Cook Medical
• W. L. Gore & Associates, Inc.
• Biotronik SE & Co. KG
• iVascular S.L.U.

The competitive landscape of the Polymer Neurovascular Stent Market is characterized by the presence of several global and regional players, each vying for market share through innovation, strategic partnerships, and product differentiation. Companies are actively investing in research and development to introduce advanced stenting technologies that meet the evolving needs of healthcare providers and patients. By focusing on enhancing the biocompatibility and functionality of their products, manufacturers are positioning themselves to capitalize on the growing demand for polymer neurovascular stents. Furthermore, collaborations between industry players and healthcare institutions are becoming increasingly common, fostering the development of tailored solutions that address specific clinical challenges.

Among the major players in the market, Medtronic stands out as a leading provider of innovative vascular therapies, including polymer neurovascular stents. The company is committed to advancing patient care through ongoing research and the development of cutting-edge technologies. Similarly, Boston Scientific Corporation and Abbott Laboratories are recognized for their extensive portfolios of neurovascular products, which include a wide range of stenting solutions designed to treat various conditions. These companies leverage their expertise in medical device manufacturing and their expansive distribution networks to reach healthcare providers and patients around the globe.

Additionally, MicroVention, Inc. and Terumo Corporation are notable contenders in the Polymer Neurovascular Stent Market, focusing on developing minimally invasive solutions for neurovascular disorders. MicroVention, in particular, has gained recognition for its innovative approaches to endovascular interventions, while Terumo is investing in enhancing its stenting technologies to improve patient outcomes. As the market continues to evolve, these companies, along with emerging players, will be instrumental in shaping the future of polymer neurovascular stents, driving advancements that align with the shifting landscape of healthcare.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Cook Medical
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Penumbra, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 iVascular S.L.U.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Cordis Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 MicroVention, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Terumo Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Abbott Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Stryker Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 B. Braun Melsungen AG
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Biotronik SE & Co. KG
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Asahi Intecc Co., Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 W. L. Gore & Associates, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Johnson & Johnson (Ethicon, Inc.)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Polymer Neurovascular Stent Sales Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Ambulatory Surgical Centers
    • 6.1.3 Specialty Clinics
  • 6.2 Polymer Neurovascular Stent Sales Market, By Product Type
    • 6.2.1 Self-Expanding Stents
    • 6.2.2 Balloon-Expandable Stents
    • 6.2.3 Drug-Eluting Stents
    • 6.2.4 Bare-Metal Stents
    • 6.2.5 Bioresorbable Stents
  • 6.3 Polymer Neurovascular Stent Sales Market, By Material Type
    • 6.3.1 Polyethylene
    • 6.3.2 Polypropylene
    • 6.3.3 Polycarbonate
    • 6.3.4 Polyurethane
    • 6.3.5 Others
  • 6.4 Polymer Neurovascular Stent Sales Market, By Distribution Channel
    • 6.4.1 Hospitals Pharmacies
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Online Pharmacies

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Polymer Neurovascular Stent Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Polymer Neurovascular Stent Sales market is categorized based on

By Product Type

• Self-Expanding Stents
• Balloon-Expandable Stents
• Drug-Eluting Stents
• Bare-Metal Stents
• Bioresorbable Stents

By Application

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Material Type

• Polyethylene
• Polypropylene
• Polycarbonate
• Polyurethane
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Boston Scientific Corporation
• Abbott Laboratories
• Cordis Corporation
• MicroVention, Inc.
• Terumo Corporation
• Stryker Corporation
• Johnson & Johnson (Ethicon, Inc.)
• Penumbra, Inc.
• B. Braun Melsungen AG
• Asahi Intecc Co., Ltd.
• Cook Medical
• W. L. Gore & Associates, Inc.
• Biotronik SE & Co. KG
• iVascular S.L.U.